| 臺大學術典藏 |
2022-01-25T05:10:37Z |
Peginterferon Alfa-2a Plus Ribavirin for the Treatment of Dual Chronic Infection With Hepatitis B and C Viruses
|
Liu C.; Chuang W.; Lee C.; Yu M.; Lu S.; Wu S.; Liao L.; CHI-LING CHEN; Kuo H.; Chao Y.; Tung S.; Yang S.; Kao J.; Liu C.; Su W.; Lin C.; Jeng Y.; Chen P.; Chen D. |
| 臺大學術典藏 |
2022-01-24T09:32:02Z |
Peginterferon Alfa-2a Plus Ribavirin for the Treatment of Dual Chronic Infection With Hepatitis B and C Viruses
|
CHUN-JEN LIU; Chuang W.; Lee C.; Yu M.; Lu S.; Wu S.; Liao L.; Chen C.; Kuo H.; Chao Y.; Tung S.; Yang S.; Kao J.; Liu C.; Su W.; Lin C.; Jeng Y.; Chen P.; Chen D. |
| 臺大學術典藏 |
2021-09-04T06:12:27Z |
Peginterferon Alfa-2a Plus Ribavirin for the Treatment of Dual Chronic Infection With Hepatitis B and C Viruses
|
Liu C.; Chuang W.; Lee C.; Yu M.; Lu S.; Wu S.; Liao L.; Chen C.; Kuo H.; Chao Y.; Tung S.; Yang S.; JIA-HORNG KAO; Liu C.; Su W.; Lin C.; Jeng Y.; Chen P.; Chen D. |
| 臺大學術典藏 |
2021-07-03T03:34:53Z |
Peginterferon Alfa-2a Plus Ribavirin for the Treatment of Dual Chronic Infection With Hepatitis B and C Viruses
|
Liu C.; Chuang W.; Lee C.; Yu M.; Lu S.; Wu S.; Liao L.; Chen C.; Kuo H.; Chao Y.; Tung S.; Yang S.; Kao J.; Liu C.; Su W.; Lin C.; Jeng Y.; PEI-JER CHEN; Chen D. |
| 臺大學術典藏 |
2021-05-24T07:20:53Z |
Peginterferon Alfa-2a Plus Ribavirin for the Treatment of Dual Chronic Infection With Hepatitis B and C Viruses
|
CHEN-HUA LIU; Chuang W.; Lee C.; Yu M.; Lu S.; Wu S.; Liao L.; Chen C.; Kuo H.; Chao Y.; Tung S.; Yang S.; Kao J.; Liu C.; Su W.; Lin C.; Jeng Y.; Chen P.; Chen D. |
| 臺大學術典藏 |
2021-03-18T08:53:58Z |
Modulators of mortality benefit from peri-angioplasty adjunctive tirofiban in patients with st-elevation myocardial infarction undergoing primary percutaneous coronary intervention
|
Yeh Y.-T.; Hsu J.-C.; Liao P.-C.; Li A.-H.; Liu Y.-H.; Chen K.-C.; Chuang W.; Ke S.-R.; Chiu Y.-W.; YEN-WEN WU |
| 臺大學術典藏 |
2020-03-06T08:25:25Z |
Peginterferon Alfa-2a Plus Ribavirin for the Treatment of Dual Chronic Infection With Hepatitis B and C Viruses
|
Liu C.; Chuang W.; Lee C.; Yu M.; Lu S.; Wu S.; Liao L.; Chen C.; Kuo H.; Chao Y.; Tung S.; Yang S.; Kao J.; Liu C.; Su W.; Lin C.; YUNG-MING JENG; Chen P.; Chen D. |
| 國立臺灣科技大學 |
2020 |
Achieving Selective Cleaning on Semiconductors Packaging Using Atmospheric Pressure Plasma
|
Kencana, S.D.;Chuang, W.;Changraini, Changraini C.;Schellkes, E.;Kuo, Y.-L.;Chang, K. |
| 國立臺灣科技大學 |
2020 |
Achieving Selective Cleaning on Semiconductors Packaging Using Atmospheric Pressure Plasma
|
Kencana, S.D.;Chuang, W.;Changraini, Changraini C.;Schellkes, E.;Kuo, Y.-L.;Chang, K. |
| 國立臺灣科技大學 |
2019 |
Improving the solder wettability via atmospheric plasma technology
|
Kencana, S.D.;Kuo, Y.-L.;Yen, Yen Y.-W.;Schellkes, E.;Chuang, W. |
| 臺大學術典藏 |
2018-09-28T04:10:30Z |
Sofosbuvir and ledipasvir are associated with high sustained virologic response and improvement of health-related quality of life in East Asian patients with hepatitis C virus infection
|
Lai C.;Chuang W.;Wei L.;Younossi Z.;Ahn S.;Nguyen K.;Chan H.;Henry L.;Stepanova M.;Han K.;Kao J.;Lim Y.; Lai C.; Chuang W.; Wei L.; Younossi Z.; Ahn S.; Nguyen K.; Chan H.; Henry L.; Stepanova M.; Han K.; Kao J.; Lim Y. |
| 國家衛生研究院 |
2009-05-20 |
Differential response of primary or secondary exon 13/14 and exon 17 c-kit mutant to nilotinib and sunitinib: Findings from a cell-based drug-screening platform
|
Chan, C;Chen, L;Hsueh, Y;Chuang, W;Lee, H;Huang, M;Heieh, R;Weng, W |
